Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
68 studies found for:    vaccine adverse reactions | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China
Condition: Influenza
Intervention: Biological: inactivated quadrivalent influenza vaccine (split virion)
2 Not yet recruiting Hepatitis B Vaccination in Infants
Conditions: Meningococcal Disease;   Pneumococcal Disease;   Haemophilus Influenzae Serotype b Disease;   Diphtheria, Tetanus and Pertussis;   Hepatitis b
Interventions: Biological: Menjugate;   Biological: Menitorix;   Biological: NeisVac-C
3 Not yet recruiting The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans
Conditions: Rabies;   Healthy
Interventions: Biological: 2.5IU/ml in rabies vaccine (MRC-5 Cell) humans aged 10-20 years old;   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans aged 21-60 years old;   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 10-20 years old);   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 21-60 years old)
4 Recruiting Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
Condition: Meningitis
Interventions: Biological: MCV-ACYW135 Vaccine Group;   Biological: MPV-ACYW135 Vaccine Group;   Biological: MPV-A Vaccine Group;   Biological: MCV-AC Vaccine Group;   Biological: Hib Vaccine Group
5 Recruiting A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland
Condition: Ebola Vaccines
Intervention: Biological: cAd3-EBOZ
6 Not yet recruiting Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Conditions: High Risk HLA-A2+ Melanoma;   Metastatic Disease
Intervention: Biological: Melanoma vaccine modified to express HLA A2/4-1BB ligand
7 Recruiting Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients
Condition: Human Influenza
Intervention: Biological: Trivalent influenza vaccine (inactivated and fragmented).
8 Recruiting A Clinical Trial for Safety & Immunogenicity Of MMR Vaccination By Disposable-Syringe Jet Injector to That by Needle And Syringe In Indian Children of 15 To 18 Months
Condition: Seroresponse to Measles, Mumps and Rubella
Intervention: Biological: MMR vaccine
9 Recruiting Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine
Condition: Meningitis
Interventions: Biological: Minhai Bio;   Biological: Hualan Bio
10 Recruiting The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Condition: Varicella
Interventions: Biological: HBV-3;   Biological: HBV-6;   Biological: varicella-3;   Biological: varicella-6
11 Unknown  Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
Conditions: HIV-1 Infection;   Cancer;   Immunosuppression
Intervention: Other: serologic testing
12 Recruiting Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Condition: Influenza, Human
Interventions: Drug: Intanza;   Drug: Vaxigrip
13 Unknown  Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine
Condition: Influenza
Intervention: Biological: 2012 trivalent influenza vaccine
14 Recruiting Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
Conditions: Immunogenicity;   Reactogenicity
Intervention: Biological: Trivivac vaccine
15 Recruiting Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia;   Non Hodgkin's Lymphoma;   Hodgkin's Disease;   Myelodysplastic Syndrome;   Multiple Myeloma;   Aplastic Anemia
Intervention: Biological: allogeneic donor derived B-lymphocytes
16 Unknown  Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
Condition: Influenza
Intervention: Drug: AdimFlu-S
17 Recruiting The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
Condition: Hepatitis B
Interventions: Drug: Alendronate;   Drug: Hepatitis B Vaccine;   Drug: Placebo
18 Recruiting αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface;   Malignant Peritoneal Mesothelioma;   Peritoneal Carcinomatosis
Interventions: Biological: DC vaccine;   Drug: Celecoxib;   Drug: Interferon Alfa-2b;   Biological: rintatolimod
19 Unknown  The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
Conditions: Immunity;   Measles;   Mumps;   Rubella
Interventions: Dietary Supplement: Probiotics (L.acidophilus and B.lactis);   Dietary Supplement: Cornflor
20 Recruiting A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men
Condition: Papilloma Viral Infection
Interventions: Biological: V503;   Biological: GARDASIL

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years